Valuation : Bayer AG

Market Cap 47.81B 55.49B 44.83B 40.92B 77.09B 5,303B 77.34B 532B 208B 2,677B 208B 204B 8,877B P/E 2026 *
21.7x
P/E 2027 * 15.9x
Enterprise Value 77.77B 90.25B 72.92B 66.56B 125B 8,626B 126B 865B 338B 4,354B 339B 331B 14,438B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.59x
Free-Float
99.99%
Yield 2026 *
0.32%
Yield 2027 * 1.09%
1 day+0.39%
1 week+1.31%
Current month+1.29%
1 month+3.49%
3 months+28.62%
6 months+15.85%
Current year+31.50%
1 week 47.54
Extreme 47.54
49.93
1 month 46.96
Extreme 46.96
50.5
Current year 32.96
Extreme 32.96
53.92
1 year 25.78
Extreme 25.78
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Date Insider Type Main position Quantity % Market Cap.
18/03/26 Buy

Director

1,900 0.0002%
18/03/26 Buy

Executive/Senior Manager

13,000 0.0013%
18/03/26 Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.39%+1.31%+74.29%-3.39% 55.49B
-0.13%-6.44%+60.47%+112.05% 1,047B
+0.85%-0.81%+52.77%+63.15% 646B
-1.03%-3.58%+22.87%+73.29% 451B
-1.46%-4.50%+37.43%+38.41% 355B
-0.72%-2.89%+21.86%+36.79% 291B
-1.19%-2.21%+1.35%+12.29% 252B
-1.05%-1.57%+51.40%+68.55% 234B
+0.08%-1.78%-17.64%-54.29% 203B
-2.14%-0.30%+29.42%+89.10% 181B
Average -0.65%-2.28%+33.42%+43.59% 371.48B
Weighted average by Cap. -0.47%-3.39%+39.19%+64.48%

Financials

2026 *2027 *
Net sales 45.77B 53.12B 42.92B 39.18B 73.8B 5,077B 74.04B 509B 199B 2,563B 199B 195B 8,498B 47.01B 54.55B 44.07B 40.23B 75.79B 5,214B 76.04B 523B 204B 2,632B 205B 200B 8,727B
Net income 2.14B 2.48B 2B 1.83B 3.44B 237B 3.46B 23.77B 9.27B 120B 9.31B 9.11B 397B 2.94B 3.41B 2.76B 2.52B 4.74B 326B 4.76B 32.72B 12.77B 165B 12.82B 12.54B 546B
Net Debt 29.95B 34.76B 28.09B 25.64B 48.3B 3,322B 48.45B 333B 130B 1,677B 131B 128B 5,561B 26.83B 31.14B 25.16B 22.96B 43.26B 2,976B 43.4B 298B 116B 1,502B 117B 114B 4,981B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
28/08/26 €48.67 +0.39% 1,453,883
27/08/26 €48.48 -1.28% 1,396,219
26/08/26 €49.11 -0.30% 1,568,001
25/08/26 €49.26 +1.61% 1,664,072
24/08/26 €48.48 +0.92% 1,532,584
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.67EUR
Average target price
57.39EUR
Spread / Average Target
+17.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock